Lee Davies

Royal Botanic Gardens, Kew — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index507citations22works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(12), RNA Interference and Gene Delivery(6), Viral gastroenteritis research and epidemiology(6), Viral Infectious Diseases and Gene Expression in Insects(4), Respiratory viral infections research(3)

Publications22 total

The first checklist of fungi known for Honduras: revealing taxonomic, geographical, and functional trends
MycoKeys·2025Open Access
Membrane adsorber design for lentiviral vector recovery
Molecular Therapy — Methods & Clinical Development·2025· 2 citedOpen Access
Auto‐transduction in lentiviral vector bioprocessing: A quantitative assessment and a novel inhibition strategy
Biotechnology and Bioengineering·2024· 3 citedOpen Access
Degradation of specific glycosaminoglycans improves transfection efficiency and vector production in transient lentiviral vector manufacturing processes
Frontiers in Bioengineering and Biotechnology·2024Open Access
Lentiviral vector determinants of anion‐exchange chromatography elution heterogeneity
Biotechnology and Bioengineering·2024· 9 citedOpen Access
Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture
Molecular Therapy — Methods & Clinical Development·2024· 8 citedOpen Access
Time‐dependent sorption behavior of lentiviral vectors during anion‐exchange chromatography
Biotechnology and Bioengineering·2023· 14 citedOpen Access
Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing
Scientific Reports·2023· 14 citedOpen Access
Thinking big: the need for innovation in the production of lentivirus-based cell and gene therapies
Cell and Gene Therapy Insights·2022Open Access
Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes
Pharmaceutics·2021· 9 citedOpen Access
Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs
Biotechnology and Bioengineering·2021· 63 citedOpen Access
Thinking big: the need for innovation in the production of lentivirus-based cell and gene therapies
Cell and Gene Therapy Insights·2021Open Access
Unlocking plant resources to support food security and promote sustainable agriculture
Plants People Planet·2020· 281 citedOpen Access
Lentiviral vector manufacturing process enhancement utilizing TFDF™ technology
Cell and Gene Therapy Insights·2020· 18 cited
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
Gene Therapy·2018· 13 citedOpen Access
Delivery of host targeted miRNA therapeutics for the treatment of respiratory viral infections
Human Gene Therapy·2015
370. F/HN Pseudotyped Lentivirus Generates Therapeutically Relevant and Long-Lasting Alpha-1-Antitrypsin Expression in Mouse Lung
Molecular Therapy·2015Open Access
171. Production of Therapeutically Relevant Levels of FVIII After Transduction of Lungs With F/HN-Pseudotyped Lentivirus
Molecular Therapy·2015Open Access
Planning of bed capacities in specialized and integrated care units: Incorporating bed blockers in a simulation of surgical throughput
Proceedings Title: Proceedings of the 2012 Winter Simulation Conference (WSC)·2012· 8 cited
Mobile Website Design
2011
page 1 of 2Next →

Frequent Co-authors

Carol Knevelman(9), Kyriacos Mitrophanous(8), Deborah R. Gill(7), Stephen C. Hyde(7), James Miskin(7), Uta Griesenbach(4), Eric W.F.W. Alton(4), Thomas J. Williams(4), Gerry McLachlan(3), George Pamenter(3), Duygu Dikicioǧlu(3), Daniel G. Bracewell(3), Michael C. Paul-Smith(3), Kamila M Pytel(3), Ian A. Pringle(3), Mario Chan(3), Makoto Inoue(3), Qasim A. Rafiq(3), Maria Kapanidou(2), Hazel Painter(2)